GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hikma Pharmaceuticals HIK.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

1,625.00p

-1.52%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

21 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 8Strong buy
  • 10Buy
  • 2Hold
  • 1Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Last close 1,625.00pAverage target 2,320.50p

Low
1,616.00p
Average
2,320.50p
Median
2,407.20p
High
2,782.50p

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue$3.45bn$3.59bn$3.76bn$3.94bn$4.13bn
Revenue, highest$3.46bn$3.63bn$3.81bn$3.97bn$4.16bn
Revenue, lowest$3.43bn$3.55bn$3.69bn$3.89bn$4.08bn
Earnings per share2.252.442.622.683.13
Earnings per share, highest2.312.512.712.713.16
Earnings per share, lowest2.132.362.562.643.09
Analysts1010944

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q4 2025Q2 2025Q2 2024Q4 2023
Forecast0.830.801.201.090.85
Reported0.950.801.211.270.93
Difference+14.5%0.0%+0.8%+16.3%+8.2%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

5 / 10

Revenue growth 8.8% a year over 10 years. Return on equity 15.8%.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.